Alnylam Pharmaceuticals (ALNY) Current Taxes (2009 - 2010)
Alnylam Pharmaceuticals posted quarterly Current Taxes of $237000.0 for Q3 2010, down 12.87% on a QoQ basis from $272000.0 in Q2 2010.
Alnylam Pharmaceuticals (ALNY) has 2 years of Current Taxes data on file, last reported at $237000.0 in Q3 2010.
- For the quarter ending Q3 2010, Current Taxes changed N/A year-over-year to $237000.0; the trailing twelve-month figure through Sep 2010 stood at $237000.0 (changed N/A YoY), and the FY2009 full-year result was $5.5 million, changed N/A from the prior year.
- Current Taxes for Q3 2010 stood at $237000.0, down from $272000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $5.5 million in Q4 2009 and bottomed at $237000.0 in Q3 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 237,000.00 |
| Jun 30, 2010 | 272,000.00 |
| Dec 31, 2009 | 5.52 Mn |